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The mouse mutant mnd2 (motor neuron degeneration 2) exhibits
muscle wasting, neurodegeneration, involution of the spleen and
thymus, and death by 40 days of age1,2. Degeneration of striatal
neurons, with astrogliosis and microglia activation, begins at
around 3 weeks of age, and other neurons are affected at later
stages3. Here we have identified the mnd2 mutation as the
missense mutation Ser276Cys in the protease domain of the
nuclear-encoded mitochondrial serine protease Omi (also
known as HtrA2 or Prss25). Protease activity of Omi is greatly
reduced in tissues of mnd2 mice but is restored in mice rescued by
a bacterial artificial chromosome transgene containing the wild-
type Omi gene. Deletion of the PDZ domain partially restores
protease activity to the inactive recombinant Omi protein carry-
ing the Ser276Cys mutation, suggesting that the mutation
impairs substrate access or binding to the active site pocket.
Loss of Omi protease activity increases the susceptibility of
mitochondria to induction of the permeability transition, and
increases the sensitivity of mouse embryonic fibroblasts to stress-
induced cell death. The neurodegeneration and juvenile lethality
in mnd2 mice result from this defect in mitochondrial Omi
protease.
mnd2 was identified in 1990 as a spontaneous, recessively
inherited mutation that arose on the C57BL/6J inbred background1.
The earliest symptoms are altered gait and cessation of normal
weight gain, followed by ataxia, repetitive movements and akinesis.
Striatal neurons are most susceptible, but other neurons in the
central nervous system, brain stem and spinal cord, including motor
neurons, are affected at later stages1,3. The neuronal degeneration
combines features of necrosis with features of apoptosis including
nuclear condensation, TdT-mediated dUTP nick end labelling
(TUNEL) staining, and DNA laddering3. Early degeneration of
mitochondria was also noted3.
To identify the molecular basis for the mnd2 disorder, we crossed
the mutant strain C57BL/6J-mnd2 with CAST/Ei2. Analysis of 1,208
F2 mice localized the gene to a 0.9-megabase (Mb) interval of mouse
chromosome 6 (Fig. 1a). The human orthologue is located in a
Figure 1 Genetic and physical map of the mnd2 region. a, Previous non-recombinant
region2. b, Reduced non-recombinant interval from the cross between C57BL/6J-mnd2
and SJL/J mice. c, Gene content of the non-recombinant region. Genes above and below
the horizontal line have opposite orientation on the chromosome. d, Overlapping BAC
clones of mouse genomic DNA spanning the non-recombinant region. A plus sign
indicates BACs that rescue the mnd2 phenotype in transgenic mice; a minus sign
indicates BACs that do not rescue the mnd2 pehonotype; a triangle indicates the position
of the BAC 177J21 deletion in transgenic line Tg410.
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gene-dense region of human chromosome 2p13 with conserved
gene order and content4. Because of the low rate of recombination
in the original cross, we initiated a second cross between strains
C57BL/6J-mnd2 and SJL/J. Recombination breakpoints in 400 F2
mice from the second cross localized mnd2 to an interval of 250
kilobases (kb) containing 14 genes (Fig. 1b, c).
Three BAC clones containing mouse genomic DNA spanning the
non-recombinant region were tested for their ability to rescue the
lethal mnd2 phenotype (Fig. 1d). Transgenic mice carrying each
BAC clone were generated by microinjection of fertilized eggs. The
mnd2 phenotype was completely corrected in transgenic line Tg514
carrying BAC clone 177J21 (Table 1). Homozygous mnd2/mnd2
mice carrying this transgene have normal weight gain and fertility,
and do not exhibit any of the phenotypic abnormalities of the mnd2
disorder. BAC clones 245C12 and 90A4 did not rescue mnd2
homozygotes. In transgenic line Tg410, a deletion occurred within
BAC 177J21, but the ability to rescue mnd2 mice was retained (Table
1). The size and position of the deletion, D177J21, was determined
by crossing the transgene onto strain SJL and testing for C57BL/6J
alleles of polymorphic D6UmiJ markers (Fig. 1d). Combining
information from the deleted BAC clone and the distal recombina-
tion breakpoint localized mnd2 to a 40-kb region containing six
candidate genes: Loxl3, Omi, Aup1, Mrpl53, Gcs1 and Wbp1 (Fig. 1,
shaded areas).
In parallel with the mapping and rescue experiments, we com-
pared the mutant and wild-type sequences for these six candidate
genes as well as most of the other genes in the original 0.9-Mb
region4–8. Comparison of .50 kb of gene sequences from mnd2 and
C57BL/6J identified only one difference, an A to T nucleotide
substitution in exon 3 of the nuclear-encoded mitochondrial serine
protease Omi (Fig. 2a). This missense mutation changes serine 276
to cysteine. Serine 276 is located in the protease domain of Omi
close to serine 306, the active site serine9, and is evolutionarily
conserved in prokaryotic and eukaryotic homologues (Fig. 2b).
Omi is localized in the intermembrane space of the mitochon-
dria10–14 and is a member of the HtrA protease-chaperone family.
Figure 2 Ser276Cys mutation in Omi. a, Nucleotide sequence chromatogram from exon 3
of wild-type (top panel), mnd2 (middle panel) and heterozygous (bottom panel) DNA. The
Prss25 mnd2 mutation, an A to T transversion at nucleotide 826, is indicated by the arrow.
b, Evolutionary conservation of Ser 276 in HtrA proteins. The AVPS motif at residues 134–
137 binds to IAPs. Ser 276 and the active site Ser 306 in the protease domain are
indicated. MTS, mitochondrial localization signal. c, Northern blot with 5 mg of poly(A)þ
RNA was hybridized with the 0.8-kb EcoRI/NotI fragment from expressed sequence tag
clone 1264040 (GenBank AA881220). d, Western blot of Omi protein in total liver extracts
from five mice of indicated genotypes. Lanes 6 and 7 contain total extracts from wild-type
mouse heart and 293T human cells, respectively. All lanes contain equal amounts of total
proteins. e, Western blot analysis of glutathione S-transferase (GST)–BIR3-bound Omi
proteins from wild-type and mnd2 liver extracts. Liver extracts from wild-type (WT) or
mnd2 mice were bound to GST (GST lanes) or GST–BIR3 (GST–BIR3 lanes) fusion protein
immobilized on glutathione-Sepharose beads. The beads were washed and the bound
proteins were eluted with SDS sample buffer and western-blotted with anti-Omi-specific
antibody. Last lane, human 293T cells.
Table 1 Transgenic rescue of mnd2 homozygotes by expression of BAC clones
BAC clone Tg line
Number of rescued mice
(mnd2/mnd2,Tg/þ)
.............................................................................................................................................................................
177J21 Tg514 21 of 21
D177J21 Tg410 10 of 10
90A4 Tg70 0 of 5
245C12 Tg666, 673 0 of 5
.............................................................................................................................................................................
Clones are described in Fig. 1d. Each transgenic line is derived from an individual founder carrying
the indicated BAC clone. Non-transgenic mnd2/mnd2 mice are severely impaired and do not
survive beyond 40 days of age. The oldest rescued mice have currently survived beyond 10
months with no phenotypic abnormalities.
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Bacterial members are quality control proteases that are essential for
surviving high temperature or oxidative stress15,16. Recently, Omi
was shown to be released from the mitochondria with cytochrome c
and Smac (also known as DIABLO) during apoptosis10–14. The
released Omi can bind to inhibitors of apoptosis proteins (IAPs),
inhibit their activity and directly degrade them17,18.
The missense mutation does not alter the size or steady-state
abundance of the Omi messenger RNA in mnd2 tissues (Fig. 2c).
Evaluation of the Omi protein also revealed no effect on the
molecular mass or protein concentration (Fig. 2d). The precursor
protein appears to be correctly processed into the mature IAP-
binding form by protease cleavage of the amino terminus in mutant
tissues (Fig. 2d). Binding of Omi to the Baculovirus Inhibitory
Repeat 3 (BIR3) domain of X-chromosome-linked IAP (XIAP) was
comparable in wild-type and mutant tissue extracts (Fig. 2e),
indicating that maturation and the IAP-binding activity of Omi
are not affected by the Ser276Cys substitution. To determine the
effect on protease activity, Omi was immunoprecipitated from liver
and assayed with 35S-labelled b-casein as substrate (Fig. 3a). No
b-casein cleaving activity was detectable in the immunoprecipitates
from mnd2 tissues (Fig. 3a). In livers of mnd2/mnd2 homozygotes
from lines Tg410 and Tg514, which are phenotypically rescued by
BAC clones 177J21 and D177J21, the protease activity of Omi is
restored (Fig. 3b).
The physiological concentration of Omi in highly expressing cells
such as 293T cells is approximately 150 nM (Fig. 2d, lane 7; see also
ref. 17). Recombinant Omi containing the Ser276Cys mutation had
no detectable protease activity at concentrations of up to seven
times this concentration (Fig. 3c, lane 5). A low level of residual
activity was only detectable at much higher concentrations (Fig. 3c,
lane 6). The mutant protein was also inactive towards the substrates
XIAP and c-IAP1 (Fig. 3d).
Although the Ser276Cys mutant does not have protease activity at
physiological concentrations, the results in Figs 2 and 3 indicate that
it is correctly processed into the mature form. These observations
suggest that processing of Omi into the mature form is probably
 
Figure 3 Effect of the Ser276Cys mutation on the protease activity of Omi. a, Loss of
serine protease activity of Omi in mnd2 tissues. Top panel: endogenous Omi was
immunoprecipitated from liver extracts of 23- and 38-day-old mice and assayed with
35S-labelled b-casein as substrate. Bottom panel: western blot of liver S100 extracts with
Omi-specific polyclonal antibody demonstrating normal amounts of protein in mnd2.
b, The Omi activity is restored in transgenic lines Tg514 and Tg410. c, Loss of activity of
recombinant Omi with the Ser276Cys mutation at near physiological concentration. Top
panel: 35S-labelled b-casein was incubated with increasing concentrations of affinity-
purified recombinant Omi. Cleavage products were analysed by SDS–PAGE and
autoradiography. Bottom panel: Coomassie-stained gel of affinity-purified Omi proteins.
The active site mutant Ser306Ala lacking activity is included as control. d, Western blot
analysis of IAP cleavage by recombinant Omi protein. Purified XIAP (left panel) or c-IAP1
(right panel) were incubated with buffer or 250 nM Omi protein. Products were separated
by SDS–PAGE and immunoblotted with antibodies against XIAP or c-IAP1 as indicated.
e, Maturation of Omi is not affected by the Ser276Cys mutation. MEFs were transfected
with constructs encoding C-terminal Flag-tagged Omi precursors. At 24 h after
transfection, cells were solubilized in SDS sample buffer, fractionated by SDS–PAGE, and
immunoblotted with anti-Flag antibody. Last lane, lysate from HeLa cells expressing
mature C-terminal Flag-tagged wild-type Omi. Asterisk, nonspecific band. The lanes
labelled buffer contain substrate incubated with buffer alone.
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catalysed by other mitochondrial proteases. To test this hypothesis,
we overexpressed wild-type Omi and the active site mutant
Ser306Ala in mouse embryonic fibroblast cells (MEFs). If Omi is
involved in its own processing, then MEFs from mnd2 mice should
be less effective in processing the inactive Ser306Ala protein. No
difference was observed in the extent of processing in wild-type and
mnd2 MEFs (Fig. 3e), indicating that other mitochondrial proteases
are involved in maturation of Omi.
In the recently published X-ray structure of Omi, Ser 276 is
located near a region critical for homotrimerization9. As formation
of a homotrimeric complex is required for protease activity, we
evaluated the effect of the mutation on trimerization. Flag- and T7-
tagged Omi proteins were co-expressed in 293T cells and cell
extracts were prepared. T7-tagged and endogenous Omi proteins
were co-immunoprecipitated with the Flag-tagged Ser276Cys pro-
tein (Fig. 4a), indicating that the mutation does not prevent
homotrimerization.
The PDZ domain in Omi restricts access of substrate to the active
site pocket9. The location of Ser 276 in the highly flexible L3 loop,
which is flanked by the PDZ domain on one side and the active site
pocket on the opposite side9,15, suggested that the Ser276Cys
mutation might negatively affect the packing interactions at the
interface between PDZ and protease domains, resulting in loss of
access to the active site pocket. Deletion of the PDZ domain
increased the activity of the wild-type protein and partially restored
the protease activity of the Ser276Cys mutant (Fig. 4b). The
Ser276Cys mutation may affect flexibility of the L3 loop, forcing
the PDZ domain into a conformation that blocks the active site
pocket of the mutant protein. Alternatively, the Ser276Cys substi-
tution may destabilize intramolecular interactions between the PDZ
and protease domains, preventing the PDZ domain from orienting
the substrate into the active site pocket. Substrate binding to the
active site may also be impaired, as deletion of the PDZ domain did
not fully restore protease activity.
The mnd2 MEFs lack Omi activity (Fig. 5a). To examine the effect
of loss of Omi protease activity on cell viability, mnd2 and wild-type
MEFs were treated with stress-inducing agents and subsequently
stained with annexin V and propidium iodide. The proportion of
stained cells was greatest in homozygous mnd2/mnd2 MEFs
(Fig. 5b), indicating increased cell death. The mnd2 MEFs exhibited
annexin V and propidium iodide staining (Fig. 5c), suggesting that
both apoptosis (annexin V) and necrosis (propidium iodide) occur
in these cells. This is consistent with observations of striatal neurons
in mnd2 mice, which combine aspects of apoptosis and necrosis3.
The caspase inhibitor z-VAD-fmk did not completely inhibit death
of mnd2 MEFs (Fig. 5d), suggesting that some cell death occurs by a
caspase-independent mechanism. The data indicate that loss of
Omi protease activity increases sensitivity to stress-induced cell
death.
Induction of the mitochondrial permeability transition can cause
mitochondrial membrane permeabilization and dysfunction lead-
ing to apoptosis and necrosis19. To determine whether the
Ser276Cys substitution in Omi affects the integrity of the mito-
chondrial membrane barrier, fluorimetric measurement of the
mitochondrial membrane potential (DWm) and cytosolic Ca
2þ
concentration ([Ca2þ]c) was carried out in permeabilized MEFs
after calcium pulsing. In surviving cells, Ca2þ is taken up by
mitochondria during [Ca2þ]c spiking and is used to stimulate
mitochondrial ATP production. However, in cells exposed to certain
pro-apoptotic agents, propagation of [Ca2þ]c signals to the mito-
chondria triggers activation of the permeability transition pore
(PTP) and mitochondrial membrane permeabilization, leading to
execution of apoptosis20. In wild-type MEFs, added Ca2þ caused
only a small and transient depolarization and was effectively
removed from cytosol by the mitochondria (Fig. 6, black traces
and bars). In contrast, in mnd2 MEFs, Ca2þ pulsing induced
relatively large and prolonged mitochondrial depolarization and a
progressive rise in [Ca2þ]c (Fig. 6, grey traces and bars). These
results suggest that mnd2 mutant cells are more vulnerable to Ca2þ-
induced permeability transition and mitochondrial membrane
permeabilization. The Ser276Cys substitution in Omi thus seems
to promote activation of the PTP by Ca2þ. As stress-inducing agents
may also target the PTP through elevation in Ca2þ concentration
or free radical formation, sensitization of the PTP in mnd2 mutant
cells provides a potential mechanism to explain the increased
sensitivity of mnd2 MEFs to stress-induced cell death, as well as
the degeneration of striatal neurons in mnd2 mice. Supporting this
mechanism, recent studies have shown that striatal mitochondria
are more vulnerable to calcium-induced permeability transition
than cortical mitochondria19. Therefore, mitochondrial dysfunction
is probably responsible for the selective death of striatal neurons in
mnd2 mice.
We have demonstrated that the Ser276Cys missense mutation in
Omi is responsible for neurodegeneration in mnd2 mutant mice.
Omi is a serine protease normally present in the intermembrane
space of mitochondria10–14. In vitro studies with cancer cell lines
have shown that release of Omi from the mitochondria into the
cytosol causes inhibition and degradation of IAPs and apoptosis17,18.
However, there are no loss-of-function models that support a role
for Omi in apoptosis in vivo. On the contrary, the data presented
here demonstrate that loss of the protease activity of Omi increases
sensitivity to stress-induced cell death and is probably responsible
for the massive loss of striatal neurons in mnd2 mutant mice3. The
data can be explained if Omi has two distinct functions: (1) under
normal physiological conditions it is required within mitochondria
for maintenance of mitochondrial homeostasis, and (2) under
apoptotic conditions it is released from mitochondria and has an
apoptotic role that is shared by other released proteins such as
cytochrome c (ref. 21) and apoptosis-inducing factor (AIF)22,23. We
Figure 4 Structural determinants of Omi activity. a, The Ser276Cys mutation does not
affect homotrimerization. (For assay conditions, see Methods section.) b, Deletion of
the PDZ domain partially restores the protease activity of the Ser276Cys Omi mutant. The
activity of the PDZ-deleted Omi proteins was determined as in Fig. 3c. Wild-type
PDZ-deleted protein catalysed the complete digestion of substrate.
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propose that the Ser276Cys mutation compromises the mitochon-
drial function, leading to mitochondrial membrane permeabiliza-
tion and cytoplasmic release of mutant Omi along with other active
inducers of cell death.
The structural similarity between Omi and bacterial HtrA pro-
teins15,16,24 suggests that Omi may be a sensor of unfolding stresses in
the mitochondria. Thus, loss of Omi protease activity in the mnd2
mice could lead to accumulation of misfolded and damaged
proteins in the mitochondria, increased susceptibility to induction
of the permeability transition and mitochondrial dysfunction.
Progressive mitochondrial dysfunction can lead to irreversible loss
of neuronal cells, and this is thought to be an important pathogenic
mechanism in many neurodegenerative disorders. Mitochondrial
disintegration is an early component of neuronal degeneration in
the striatum of mnd2 mice3. The dying striatal neurons exhibit
features of apoptosis such as condensation of nuclear DNA, nuclear
shrinkage, TUNEL staining and DNA laddering3. Some cells also
exhibit features of necrosis3. This neuronal degradation was not
prevented by overexpression of Bcl2 (ref. 3). The loss of protein
quality control in the mitochondria can account for both types of
cell death in mnd2 mice. Induction of mitochondrial permeability
transition due to accumulation of misfolded proteins might lead to
release of the mitochondrial apoptotic proteins that activate the
caspase-dependent and -independent cell death cascades. At the
same time, the loss of mitochondrial respiratory competence, and
reduced intracellular ATP levels, might result in rupture of the
plasma membrane and necrotic cell death25.
AIF is a nuclear-encoded mitochondrial protein that is localized
in the intermembrane space and is involved in apoptosis26. In the
mouse mutant harlequin (Hq), AIF expression is reduced to 20% of
normal, resulting in oxidative stress and degeneration of cerebellar
neurons23. The mechanism of cell death in this mutant is loss of the
hydrogen peroxide scavenger function of AIF. BAD is another
protein involved in apoptosis, which has recently been shown to
reside in a mitochondrial complex that integrates glycolysis and
apoptosis27. Similar to Omi, these proteins combine an essential
mitochondrial function with a role in inducing apoptosis. The
human neurodegenerative disease hereditary spastic paraplegia
(SPG7) is also caused by inactivation of a mitochondrial protease
called paraplegin28. The yeast homologues of paraplegin, known as
AAA proteases, are quality control protease-chaperons anchored to
the inner mitochondrial membrane29. In both SPG7 and mnd2 the
Figure 5 Sensitivity of mnd2 MEFs to stress-induced cell death. a, The top panel shows
protease activity of Omi in cultured MEFs. Activity was determined as in Fig. 3a. The
bottom panel shows western blot of MEF extracts with Omi-specific antibody. b, MEFs
were treated with stress-inducing agents and then stained with annexin V and propidium
iodide. The percentage of cell death was determined as described in Methods. UT,
untreated. c, Representative fields of control (untreated) MEFs and treated MEFs
stained with annexin V (green fluorescence) and propidium iodide (PI, orange
fluorescence). Cells were visualized by fluorescence microscopy ( £ 10). d, z-VAD-fmk
partially inhibits stress-induced cell death of mnd2 MEFs. MEFs were treated with
antimycin A or etoposide in the presence (þ) or absence (2) of the pan-caspase inhibitor
z-VAD-fmk.
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cause of mitochondrial dysfunction and neurodegeneration may
include defective protein quality control, in the mitochondrial
matrix or intermembrane space, respectively. It remains to be seen
whether spontaneous mutations in Omi are responsible for neuro-
degeneration disorders in humans.
Note added in proof: The human OMI gene is located near the
Parkinson’s disease susceptibility locus PARK3 on chromosome
2p13.1. No coding or splice site mutations of human OMI were
detected in two families with Parkinson’s disease mapped to the




The mnd2 mutation arose on strain C57BL/6J in 1990 at the University of Michigan.
C57BL/6J-mnd2/þ males were mated with SJL/J females. The F1 offspring were test-
crossed with C57BL/6J-mnd2/þ mice. Confirmed heterozygotes were intercrossed to
generate F2 mice. C57BL/6J and SJL/J mice were obtained from the Jackson Laboratory.
BAC transgenic mice
BAC clones RP23-177J21 and RP23-90A4 were obtained from BAC/PAC resources
(Oakland Children’s Hospital); clone 245C12 has been described previously2. DNA from
BAC clones was purified with Nucleobond columns (BD Biosciences-ClonTech) (http://
www.med.umich.edu/tamc/BACnucleo.html). Female F2 heterozygotes from the SJL cross
were superovulated and mated with F1 heterozygous males to generate fertilized eggs for
microinjection. Transgenic founders were identified by polymerase chain reaction (PCR)
amplification of tail DNA using BAC-specific primers flanking each vector-insert junction.
The integrity of the BAC transgenes 177J21 and 90A4 were analysed by crossing onto a
homozygous SJL/J background and detection of C57BL/6J alleles of the appropriate
D6UmiJ markers (Fig. 1a, b). The integrity of BAC 245C12 was evaluated by detection of
alleles from strain 129/Sv on a C57BL/6J background.
Markers and genotyping
Nineteen new genetic markers, D6UmiJ1 to D6UmiJ27, with different alleles in C57BL/6J
and SJL/J were generated using primers flanking microsatellite sequences in the C57BL/6J
genome. Primer sequences and allele sizes are available from the Mouse Genome Database
(www.informatics.jax.org). The Ser276Cys mutant allele of Omi, designated Prss25mnd2, is
detected by amplification of a 500-base pair (bp) fragment containing exon 3 from
genomic DNA using the primers mnd2F (5 0 -CACACTGAGGATTCAAACCAAGGT-3
0
)
and mnd2R (5 0 -GACCGAGGACATAAACAGGGTGTA-3 0 ). Digestion with AluI produces
a 244-bp product from the mutant allele in place of wild-type fragments of 171 bp and
73 bp. PCR of genomic DNA was carried out using the primers described in the text, in a
volume of 25 ml containing £ 1 Taq DNA polymerase buffer (Promega), 2.5 mM MgCl2,
0.2 mM dNTPs, 0.5 mM primers and 1 U Taq DNA polymerase in storage buffer B
(Promega). Incubation at 94 8C for 2 min was followed by 34 cycles of 94 8C for 45 s, 60 8C
for 45 s, and 72 8C for 45 s, followed by 72 8C for 10 min. PCR products were separated on
2% agarose gels and stained with ethidium bromide.
DNA sequence
The DNA sequences of BAC clones RP23-177J21 and b245C12 are described in GenBank
under accession numbers AC104324 and AC003061, respectively. Exons of positional
candidate genes were amplified from wild-type and mnd2/mnd2 samples by PCR or PCR
with reverse transcription (RT) and sequenced by the University of Michigan DNA
Sequencing Core.
Complementary DNA cloning and recombinant protein expression
The wild-type full-length mouse Omi cDNA clone (GenBank AF175324) was obtained
from A. Zervos. Constructs encoding wild-type and mutant full-length and mature Omi
proteins were generated by PCR and overlapping PCR, using modified complementary
PCR adaptor-primers. Carboxy-terminal Flag, T7 or (His)6 tagging was carried out by
cloning the PCR-generated cDNAs in-frame into Flag-C-pcDNA3, T7-C-pcDNA3 or
pET-21 expression vectors respectively. The human b-casein cDNA was isolated from
human placenta by RT–PCR and cloned into pcDNA3 to generate the pcDNA-b-casein
plasmid. All expression constructs were sequenced by the Kimmel Cancer Institute DNA
sequencing core. Mature mouse Omi was overexpressed in Escherichia coli strain
BL21(DE3) as a C-terminally (His)6-tagged protein using a pET-21 vector. 35S-labelled b-
casein protein was prepared by in vitro translation in the presence of 35S-methionine using
the TNT rabbit reticulocyte lysate kit from Promega. XIAP and c-IAP1 were expressed in
bacteria as described10,17.
GST–BIR3 pull-down assay
This assay was performed essentially as described10.
Protease assay
The protease activity of recombinant wild-type and mutant Omi was assayed with the
substrates 35S-labelled b-casein, c-IAP1 or XIAP as described previously17. Different
amounts of bacterially expressed (His)6-tagged Omi was purified on Talon affinity
resins and then incubated with 35S-labelled b-casein or IAPs in an assay buffer
containing 25 mM Tris, pH 7.6, 100 mM NaCl, 250 mM imidazole and 1 mM
dithiothreitol for 1 h at 37 8C in a total 50-ml reaction. Cleavage products were analysed by
SDS–polyacrylamide gel electrophoresis (PAGE) and visualized by autoradiography or
western blotting.
Endogenous Omi proteins were isolated by immunoprecipitation before protease
assay. Frozen livers from mnd2 and control mice were homogenized in a buffer containing
50 mM Tris, pH 7.6, 150 mM NaCl, 0.1% NP-40 and protease inhibitors, and centrifuged
at 20,000g. The supernatants were further centrifuged at 100,000g and the resulting S100
extracts were incubated with an Omi-specific polyclonal antibody17 for 1 h. After
incubation, the Omi–antibody complexes were bound to protein G Sepharose and washed
several times. The protein G Sepharose-bound complexes were incubated with 35S-labelled
b-casein in an assay buffer (25 mM HEPES, pH 7.6, 10 mM KCl, 1.5 mM MgCl2, 1 mM
EDTA, 1 mM EGTA) for 1 h at 37 8C in a total 50 ml reaction. Cleavage products were
analysed by SDS–PAGE and visualized by autoradiography. Omi activity in MEFs was
assayed by the same method.
Trimerization assay
293T cells were co-transfected with constructs encoding C-terminal Flag-tagged and T7-
tagged Omi variants (wild type, S276C, S306A) using the Lipofectamine method. At 36 h
after transfection, cells were lysed and the cellular lysates were immunoprecipitated with a
Flag-specific antibody. The immunoprecipitates were analysed by western blotting with a
T7-specific or Omi-specific antibodies.
Cell death assay
MEFs were grown in DMEM supplemented with 10% FBS and penicillin/streptomycin.
MEFs were seeded in 12-well plates at a density of 5 £ 104 cells per well and treated with
antimycin A (100 mg ml21 for 12 h), hydrogen peroxide (3 mM for 5 h), etoposide
(100 mg ml21 for 12 h), or tunicamycin (2.5 mg ml21 for 12 h) in the presence or absence of
z-VAD-fmk (50 mM). Cells were stained with annexin V and propidium iodide
(CLONTECH Laboratories) as per the manufacturer’s recommendations and counted.
Normal cells and dead cells (annexin V and/or propidium iodide positive) were counted
using fluorescence microscopy. The percentage of dead cells in each experiment was
expressed as the mean percentage of dead cells as a fraction of the total number of cells
counted. Data represent mean values from three experiments.
DWm and [Ca
21]c assay
Measurement of DWm and [Ca
2þ]c in permeabilized MEFs was carried out as described
previously20. Equal aliquots of cells (2.4 mg protein) were resuspended and permeabilized
with 40 mg ml21 digitonin in 1.5 ml of an intracellular medium composed of 120 mM KCl,
10 mM NaCl, 1 mM KH2PO4, 20 mM HEPES/Tris, pH 7.2 supplemented with 1 mg ml
21
of each of the following: antipain, leupeptin, pepstatin. Measurements were carried out in
Figure 6 Ca2þ pulsing-induced mitochondrial membrane permeabilization in mnd2
MEFs. a, DW m (top) and [Ca
2þ]c (bottom) recordings from mnd2/mnd2 (grey) and wild-
type (black) MEFs. Additions: Ca2þ, 30 mM CaCl2 at each arrow; uncoupler, 1 mM FCCP.
Data are representative of 5–6 different measurements. b, Quantification of mitochondrial
depolarization in response to Ca2þ pulsing. To quantify Ca2þ-induced depolarization, the
Ca2þ-induced decrease in the JC1 fluorescence ratio R JC1 was normalized to the
uncoupler-induced decrease in R JC1 in both mnd2/mnd2 and wild-type MEFs.
c, Determination of mitochondrial Ca2þ uptake. To evaluate mitochondrial Ca2þ uptake,
the duration at half maximum of the [Ca2þ]c transient evoked by the fourth Ca
2þ pulse
was calculated. Data from separate experiments are shown as mean ^ s.e.m.
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the presence of 2 mM MgATP, 5 mM phosphocreatine, 5 U ml21 creatine kinase and 2 mM
succinate.
To carry out simultaneous measurements of [Ca2þ]c and DWm, the permeabilized cells
were supplemented with 0.5 mM fura2FF/FA and 800 nM JC1. Fluorescence was
monitored in a multi-wavelength-excitation dual wavelength-emission fluorimeter
(DeltaRAM, PTI) using 340- and 380-nm excitation and 535-nm emission for fura2FF
whereas 490-nm excitation/535-nm emission and 570-nm excitation/595-nm emission
were used for JC1. DWm is shown as the ratio of the fluorescence of J-aggregate (excitation
570 nm/emission 595 nm) and monomer (excitation 490 nm/emission 535 nm) forms of
JC1. Calibration of fura2FF signal was carried out by adding CaCl2 (2.5 mM) and
subsequently EGTA/Tris (10 mM) at pH 8.5. Experiments were carried out at 35 8C and
with simultaneous stirring.
Received 31 July; accepted 15 September 2003; doi:10.1038/nature02052.
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Insulin stimulates glucose uptake in fat and muscle by mobilizing
the GLUT4 glucose transporter. GLUT4 is sequestered intracellu-
larly in the absence of insulin, and is redistributed to the plasma
membrane within minutes of insulin stimulation1,2. But the
trafficking mechanisms that control GLUT4 sequestration have
remained elusive. Here we describe a functional screen to identify
proteins that modulate GLUT4 distribution, and identify TUG as
a putative tether, containing a UBX domain, for GLUT4. In
truncated form, TUG acts in a dominant-negative manner to
inhibit insulin-stimulated GLUT4 redistribution in Chinese
hamster ovary cells and 3T3-L1 adipocytes. Full-length TUG
forms a complex specifically with GLUT4; in 3T3-L1 adipocytes,
this complex is present in unstimulated cells and is largely
disassembled by insulin. Endogenous TUG is localized with the
insulin-mobilizable pool of GLUT4 in unstimulated 3T3-L1
adipocytes, and is not mobilized to the plasma membrane by
insulin. Distinct regions of TUG are required to bind GLUT4 and
to retain GLUT4 intracellularly in transfected, non-adipose cells.
Our data suggest that TUG traps endocytosed GLUT4 and tethers
it intracellularly, and that insulin mobilizes this pool of retained
GLUT4 by releasing this tether.
The proportion of GLUT4 at the surface of individual living cells
was assayed by using flow cytometry to measure fluorescence
intensities corresponding to cell surface and total GLUT4. For
this, we used a previously described GLUT4 reporter protein
containing epitope tags in its first extracellular domain and green
fluorescent protein (GFP) at the carboxy terminus3. To identify
proteins that alter GLUT4 distribution, we constructed a 3T3-L1
adipocyte complementary DNA library in a retroviral vector. We
used the pMX-IRES-CD2 vector because it produces a bicistronic
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